Plain-English translation of NCT06894212 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Read our Schizophrenia research guide βPhase 3 β Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help people who are experiencing a sudden worsening of psychotic symptoms from schizophrenia. Researchers want to learn whether this medication works better than placebo (a dummy pill) and is safe to use. Some participants will receive the medication at different doses, while others will receive placebo.
Currently available antipsychotic medications don't work well for everyone, and some people develop severe side effects. This trial is exploring whether this new treatment might offer a better option for people in crisis with acute psychotic symptoms.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You will be randomly assigned to take either the new medication at one of two doses or a placebo pill. You will take this daily while being monitored in a hospital or outpatient setting, depending on the severity of your symptoms. The research team will regularly check how you are responding, monitor for any side effects, and support your recovery throughout the study period.
AI-generated summary from trial data Β· Jul 3, 2026 Β· Not medical advice
United States